EU project develops software to improve brain tumour diagnosis

A recently launched EU funded HealthAgents project (and recent Best IST Project Website Award winner) is developing software which is likely to give doctors everywhere much-needed help in the early diagnosis and treatment of brain tumours.

Brain tumours remain an important cause of mortality and afflict a large percentage of the European population. In children over one year of age, brain tumours are the most common solid malignancies that cause disease-related death.

A brain tumour diagnosis usually involves using Magnetic Resonance Spectroscopy (MRS), a non-invasive technique, to determine the tissue biochemical composition of a tumour. But such scans only achieve 60-90% accuracy, depending on the tumour type and grade.

Diagnosing a tumour, therefore, also requires taking a surgical biopsy, which can be potentially deadly for patients. For tumours that evolve slowly - mainly in children - repeated biopsies are often needed, but are not advisable.

Now, research teams from Belgium, Italy, Spain and the UK, working together in HealthAgents - a €4.5 initiative - hope that with their software, biopsies will no longer be necessary.

They will develop a database in which hi-tech scans, conducted on patients in hospitals from all around Europe, may be stored and classified. Using pattern recognition techniques, the system will enable doctors to compare the scan results with those from similar cases from other hospitals. The software will then suggest a series of diagnoses, leaving the doctor to choose the best type of treatment.

According to Dr Andrew Peet, clinical advisor to HealthAgents, the project gives doctors access to a range of securely held results that would simply not have been available previously. "The consortium encompasses a wide range of talent from universities, companies and hospitals. The expertise of the consortium will provide the foundations for the first EU grid for brain tumour diagnosis and prognosis. We will profit from a world-class data exchange network to address one of the most pernicious diseases of our time," he said.

For further information, please visit:
www.healthagents.net

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Philips Launches HealthSuite Clinical Tr…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced Clinical Trial Accelerator on Philips HealthSuite. This new tailored set of capabilities allows life science organizations to...

New AI Diagnostic can Predict COVID-19 w…

Researchers at King's College London, Massachusetts General Hospital and health science company ZOE have developed an artificial intelligence diagnostic that can predict whether someone is likely to have COVID-19 based...

Biomax Provides AI-Based Semantic Search…

The bioinformatics company Biomax, headquartered in Planegg, Germany, makesitssemantic search platform AILANI available free of charge to research institutes around the world in order to support the rapid and successful...

COVID-19 and Health Tech: Building on th…

Highland Marketing's advisory board met to discuss the health tech response to the coronavirus outbreak. In many areas, this has been hugely impressive: but there are gaps, and there will...

InsurTech Hub Munich and dmac/Digital He…

InsurTech Hub Munich (ITHM) and dmac - Medical Valley Digital Health Application Center part of the Digital Health Hub Nuremberg/Erlangen announce a new cross-industry accelerator for the second half of...

Viveo Health Offers Free Telemedicine So…

Viveo Health, a global e-Health innovator, is making its 'Virtual Office for Doctors' platform free of charge to doctors and other medical professionals worldwide in light of the surge in...

Telemedicine Transforms Response to COVI…

A rapid increase in "virtual" visits during the COVID-19 pandemic could transform the way physicians provide care in the United States going forward, according to a new study led by...

The Dedalus Group, Participated by Ardia…

The Dedalus Group, a leading European company, and one of the worldwide main ones, active in clinical healthcare information systems to support clinical professionals and organizations in order to improve...

Supercomputer Simulations Present Potent…

Several drugs approved for treating hepatitis C viral infection were identified as potential candidates against COVID-19, a new disease caused by the SARS-CoV-2 coronavirus. This is the result of research...

The COVID-19 pandemic reveals the potent…

Two new articles provide insights on the use of telehealth or virtual care in the age of COVID-19 and beyond, pointing to its value to not only prevent contagious diseases...

DigiConnect: e-healthcare - 24/7 Health …

Given the current outbreak of COVID-19, healthcare providers in the Middle East along with the rest of the world are currently putting relentless efforts to provide an innovative offering that...

WiFi SPARK Works with Visionable to Conn…

Seven NHS Trusts are using technology developed by WiFi SPARK in response to an urgent request from leading NHS Trusts to find a way to connect hospital patients with their...